@article{2714cceb7301417d85c3c4f7ecd9656e,
title = "Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply",
author = "Ikuo Hirano and Dellon, {Evan S.} and Gupta, {Sandeep K.} and Katzka, {David A.} and Collins, {Margaret H.} and Wojtowicz, {Abigail M.} and Brian Terreri and Wenwen Zhang and Mena Boules and Siddharth Bhatia and Desai, {Nirav K.}",
note = "Funding Information: : Medical writing support was provided by Joanna L Donnelly, PhD, of PharmaGenesis London, London, UK, and funded by Takeda Pharmaceuticals USA, Inc. The authors' declarations of personal and financial interests are unchanged from those in the original article. Declaration of personal interests 2 ",
year = "2023",
month = may,
doi = "10.1111/apt.17476",
language = "English (US)",
volume = "57",
pages = "1163--1165",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "10",
}